Brigit Biofarmaka Teknologi Tbk. vs Saratoga Investama Sedaya Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Saratoga Investama Sedaya Tbk. trades at Rp1,760 (market cap 24.35T, 6.81M 24h volume). The key difference: Saratoga Investama Sedaya Tbk. is far larger — about 140.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Saratoga Investama Sedaya Tbk. is more actively traded (6.81M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SRTG | |
|---|---|---|
Market Cap | 172.82B | 24.35T |
Volume | 592.2K | 6.81M |
Lot | 5.92K | 68.09K |
Turnover | 147.05M | 12.03B |
Average Price | 248.31 | 1,766.82 |
Value | 147.05M | 12.03B |
Indicative Equilibrium Price | 254 | 1,760 |
Indicative Equilibrium Volume | 10 | 538 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Saratoga Investama Sedaya Tbk (the Company) was established in Jakarta based on Notarial Deed No. 41 dated May 17, 1991 in conjuction with Notarial Deed No.33 dated July 13 1992, both of Ny. Rukmasanti Hardjasatya, SH., Notary in Jakarta.
Read more on SRTG →